390 related articles for article (PubMed ID: 8093892)
1. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of an Mls-1-specific monoclonal antibody.
Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein.
Acha-Orbea H; Scarpellino L; Shakhov AN; Held W; MacDonald HR
J Exp Med; 1992 Dec; 176(6):1769-72. PubMed ID: 1334118
[TBL] [Abstract][Full Text] [Related]
5. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).
Held W; Shakhov AN; Waanders G; Scarpellino L; Luethy R; Kraehenbuhl JP; MacDonald HR; Acha-Orbea H
J Exp Med; 1992 Jun; 175(6):1623-33. PubMed ID: 1316932
[TBL] [Abstract][Full Text] [Related]
6. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
7. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
8. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
9. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
10. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
11. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
[TBL] [Abstract][Full Text] [Related]
12. Neonatal impaired response to viral superantigen encoded by MMTV(SW) and Mtv-7.
Le Bon A; Desaymard C; Papiernik M
Int Immunol; 1995 Dec; 7(12):1897-903. PubMed ID: 8746559
[TBL] [Abstract][Full Text] [Related]
13. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
[TBL] [Abstract][Full Text] [Related]
14. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
15. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
16. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
17. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.
Held W; Waanders GA; Shakhov AN; Scarpellino L; Acha-Orbea H; MacDonald HR
Cell; 1993 Aug; 74(3):529-40. PubMed ID: 8394220
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of Mls-1.
Beutner U; Rudy C; Huber BT
Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
[TBL] [Abstract][Full Text] [Related]
19. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.
Golovkina TV; Chervonsky A; Dudley JP; Ross SR
Cell; 1992 May; 69(4):637-45. PubMed ID: 1316806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]